BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 15223167)

  • 21. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
    Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of cervical cancer in Taiwan.
    Wang PD; Lin RS
    Gynecol Oncol; 1996 Sep; 62(3):344-52. PubMed ID: 8812531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in gynecologic cancer among elderly women in Denmark, 1980-2012.
    Ør Knudsen A; Schledermann D; Nyvang GB; Mogensen O; Herrstedt J;
    Acta Oncol; 2016; 55 Suppl 1():65-73. PubMed ID: 26784001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003 - 2007].
    Wei KR; Chen WQ; Zhang SW; Zheng RS; Wang YN; Liang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):445-51. PubMed ID: 22932112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
    Hannibal CG; Cortes R; Engholm G; Kjaer SK
    Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years.
    Huang Z; Zheng Y; Wen W; Wu C; Bao P; Wang C; Zhong W; Gao YT; Jin F; Xiang YB; Shu XO; Beeghly-Fadiel A
    Eur J Cancer; 2016 Aug; 63():1-10. PubMed ID: 27254837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine cancers in Alberta: trends of incidence and mortality.
    King HS; Wigle DT; Hill GB; Silins J
    Can Med Assoc J; 1982 Oct; 127(7):591-4. PubMed ID: 7127226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries.
    Kjaerbye-Thygesen A; Huusom LD; Frederiksen K; Kjaer SK
    Acta Obstet Gynecol Scand; 2005 Oct; 84(10):1006-12. PubMed ID: 16167920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The Netherlands.
    Koper NP; Kiemeney LA; Massuger LF; Thomas CM; Schijf CP; Verbeek AL
    Obstet Gynecol; 1996 Sep; 88(3):387-93. PubMed ID: 8752245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends of cervical cancer mortality in the member states of the European Union.
    Arbyn M; Raifu AO; Weiderpass E; Bray F; Anttila A
    Eur J Cancer; 2009 Oct; 45(15):2640-8. PubMed ID: 19695864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gynaecologic cancer incidence, Kingston and St Andrew, Jamaica, 1973-1997, and gynaecologic cancer mortality, Jamaica, 1999.
    Blake G; Hanchard B; Gibson T; Wolff C; Samuels E; Waugh N; Simpson D
    West Indian Med J; 2003 Dec; 52(4):273-7. PubMed ID: 15040060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolution of HPV-related anogenital cancers reported in Quebec - incidence rates and survival probabilities.
    Louchini R; Goggin P; Steben M
    Chronic Dis Can; 2008; 28(3):99-106. PubMed ID: 18341764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Problem of uterine and ovarian cancer mass screening].
    Ohmura M; Oda M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Methodologic and organizational principles of selective screening for cervical, endometrial and ovarian carcinoma].
    Zalutskiĭ IV; Vishnevskaia EE; Kurian LM
    Vopr Onkol; 2006; 52(1):74-7. PubMed ID: 16715709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of department volume on cancer survival for gynaecological cancers--a population-based study in Tyrol, Austria.
    Oberaigner W; Stühlinger W
    Gynecol Oncol; 2006 Nov; 103(2):527-34. PubMed ID: 16730055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends and differentials in ovarian cancer: incidence, mortality and survival experience.
    Hanai A
    APMIS Suppl; 1990; 12():1-20. PubMed ID: 2190628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The epidemiology of cancers of the female genital organs].
    Kato I; Tominaga S; Kuroishi T
    Gan No Rinsho; 1989 Jan; 35(1):1-8. PubMed ID: 2646463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence of female breast and genital cancer: analysis of the age-dependence.
    Dix D; Cohen P; Barzegar S
    Anticancer Res; 1983; 3(4):251-5. PubMed ID: 6881922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of gynecological cancer and survival of patients].
    Merabishvili VM; Bakhidze EV; Laliantsi ÉI; Urmancheeva AF; Krasil'nikov IA
    Vopr Onkol; 2014; 60(3):288-97. PubMed ID: 25033679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent trends in recorded incidence and mortality from uterine cancer.
    Gallagher RP; Elwood JM
    Natl Cancer Inst Monogr; 1982; 62():83-7. PubMed ID: 7167199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.